Informazioni sul prodotto
- NSC 145668 HCl, Cyclocytidine hydrochloride, Cyclo-CMP hydrochloride, Cyclocytidine HCl, Cyclo-C
- (2R,3R,3aS,6E,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol
- (6E)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol
- 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride
- 2,2'-Anhydro-cytidine Hydrochloride
- 2,2'-O-Cyclocytidine Hydrochloride
- 2,2'-dihydro-1-beta-D-arabinofuranosylcytosine hydrochloride
- 2,2′-Anhydro-1-β-<span class="text-smallcaps">D</span>-arabinofuranosylcytosine hydrochloride
- 2,2′-Anhydro-1-β-<span class="text-smallcaps">D</span>-arabinofuranosylcytosine monohydrochloride
- 2,2′-Anhydroarabinosylcytosine hydrochloride
- Vedi altri sinonimi
- 2,2′-Anhydroaracytidine hydrochloride
- 2,2′-Anhydrocytidine hydrochloride
- 2,2′-Cyclocytidine hydrochloride
- 2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol
- 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, hydrochloride
- 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, hydrochloride (1:1), (2R,3R,3aS,9aR)-
- 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, (2R,3R,3aS,9aR)-
- 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, [2R-(2α,3β,3aβ,9aβ)]-
- 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, stereoisomer
- Cyclo-CMP hydrochloride
- NSC 145668
- O<sup>2</sup>,O<sup>2′</sup>-Anhydro-1-β-<span class="text-smallcaps">D</span>-arabinofuranosylcytosine monohydrochloride
- O<sup>2</sup>,O<sup>2′</sup>-Anhydro-1-β-arabinofuranosylcytosine hydrochloride
- OCTD hydrochloride
Ancitabine hydrochloride (NSC 145668 HCl) is the hydrochloride salt of a cytarabine congener prodrug with antineoplastic activity. Upon administration, ancitabine is slowly hydrolyzed into cytarabine. Subsequently, cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. Cytarabine agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Compared to cytarabine, a more prolonged, consistent cytarabine-mediated therapeutic effect may be achieved with ancitabine because of the slow hydrolytic conversion of ancitabine to cytarabine.
Proprietà chimiche
Richiesta tecnica su: TM-T1591 Ancitabine hydrochloride
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.